The following information may help to address your question:
Can bisphosphonate therapy stop the progression of fibrous dysplasia in adults?
Is the long-term use of bisphosphonates for treatment of fibrous dysplasia associated with an increased risk for bone fracture?
So far studies investigating the use of bisphosphonate therapies for treatment of fibrous dysplasia have been small and uncontrolled. Further information regarding the benefits and complications associated with bisphosphonate therapy for treatment of fibrous dysplasia is likely on the horizon. The National Institute of Dental and Craniofacial Research at the National Institutes of Health completed a three year, phase 2,
National Library of Medicine Customer Service
Toll-free: 888-346-3656
E-mail: custserv@nlm.nih.gov
In addition, there is an ongoing clinical trial in Europe, entitled Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone (PROFIDYS), that is investigating the efficacy of oral bisphosphonate to decrease bone pain and improve radiological appearance of fibrous dysplasia. Click on the title above to learn more.
We hope this information is helpful. We strongly recommend you discuss this information with your doctor. If you still have questions, please contact us.
Warm regards,
GARD Information Specialist
Please see our Disclaimer.